Expanding the action of duplex RNAs into the nucleus: redirecting alternative splicing
Authors:
Open Access
- 23 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 40 (3) , 1240-1250
Abstract
Double-stranded RNAs are powerful agents for silencing gene expression in the cytoplasm of mammalian cells. The potential for duplex RNAs to control expression in the nucleus has received less attention. Here, we investigate the ability of small RNAs to redirect splicing. We identify RNAs targeting an aberrant splice site that restore splicing and production of functional protein. RNAs can target sequences within exons or introns and affect the inclusion of exons within SMN2 and dystrophin, genes responsible for spinal muscular atrophy and Duchenne muscular dystrophy, respectively. Duplex RNAs recruit argonaute 2 (AGO2) to pre-mRNA transcripts and altered splicing requires AGO2 expression. AGO2 promotes transcript cleavage in the cytoplasm, but recruitment of AGO2 to pre-mRNAs does not reduce transcript levels, exposing a difference between cytoplasmic and nuclear pathways. Involvement of AGO2 in splicing, a classical nuclear process, reinforces the conclusion from studies of RNA-mediated transcriptional silencing that RNAi pathways can be adapted to function in the mammalian nucleus. These data provide a new strategy for controlling splicing and expand the reach of small RNAs within the nucleus of mammalian cells.Keywords
Funding Information
- National Institutes of Health
This publication has 39 references indexed in Scilit:
- The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular DystrophyMolecular Therapy, 2011
- Alternative splicing and evolution: diversification, exon definition and functionNature Reviews Genetics, 2010
- RNA-targeted splice-correction therapy for neuromuscular diseaseBrain, 2010
- Splicing, cis genetic variation and diseaseBiochemical Society Transactions, 2009
- Therapeutic Potential of Splice-Switching OligonucleotidesOligonucleotides, 2009
- Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomersBiochemical Journal, 2008
- Antisense-mediated exon skipping: A versatile tool with therapeutic and research applicationsRNA, 2007
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathologyNature Medicine, 2006
- Systemically delivered antisense oligomers upregulate gene expression in mouse tissuesNature Biotechnology, 2002
- Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.Proceedings of the National Academy of Sciences, 1993